Universit�Tsklinikum Schleswig-Holstein

Kiel D-24105

2 studies enrolling now · 21 studies all time

What they study most

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aortic Valve Stenosis, BMM, Bone Marrow Mastocytosis, Bullous Pemphigoid, Cardiovascular Diseases, Congenital Heart Disease, Congestive Heart Failure, Diverticulitis, Heart Valve Diseases, ISM

Studies at this site

• A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis — Recruiting now
• Study to Assess Safety of HDP-101 in Patients With Relapsed Refractory Multiple Myeloma — Recruiting now
• A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis — Recruiting now
• A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Relapsing Multiple Sclerosis (RMS) — Running, not enrolling
• A Randomised Trial of S-ICD Implantation With and Without Defibrillation Testing — Completed
• (Summit) A Study to Evaluate the Efficacy and Safety of CGT9486 Versus Placebo in Patients With Indolent or Smoldering Systemic Mastocytosis — Running, not enrolling
• Distal Ischemic Stroke Treatment With Adjustable Low-profile Stentriever — Running, not enrolling
• Phosphatase Inhibition by Intracoronary Gene Therapy in Subjects With Non-Ischemic NYHA Class III Heart Failure — Running, not enrolling
• A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) — Completed
• Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) — Withdrawn before enrolling
• A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Remission — Stopped early
• Phase 3 Randomized, Open-Label Study of Guadecitabine vs Treatment Choice in Previously Treated Acute Myeloid Leukemia — Completed
• A Phase 1 Study of AMG 330 in Subjects With Myeloid Malignancies — Stopped early
• Blinatumomab in Combination With AMG 404 for the Treatment of Adults With Relapsed or Refractory B Cell Precursor ALL — Completed
• Effect of Tiotropium (Spiriva) on Exercise Tolerance in COPD Patients — Completed
• Prevention of Recurrence of Diverticulitis — Completed
• Comparison of a Rivaroxaban-based Strategy With an Antiplatelet-based Strategy Following Successful TAVR for the Prevention of Leaflet Thickening and Reduced Leaflet Motion as Evaluated by Four-dimensional, Volume-rendered Computed Tomography (4DCT) — Completed
• Clinical Study With Blinatumomab in Patients With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ALL) — Completed
• Study to Demonstrate the Efficacy and Safety of Propranolol Oral Solution in Infants With Proliferating Infantile Hemangiomas Requiring Systemic Therapy — Completed
• A Study to Evaluate MEDI-524 In Children With Hemodynamically Significant Congenital Heart Disease — Completed
• Phase III Randomized Study of Amonafide (AS1413) and Cytarabine Versus Daunorubicin and Cytarabine in Patients With Secondary Acute Myeloid Leukemia (AML)- the ACCEDE Study — Status unconfirmed